Biotech News
Related news
OSUROraSure Technologies, Inc.2026-10-26 20:05 EST
OraSure to Announce Third Quarter 2026 Financial Results and Host Earnings Call on November 9th
SABSSAB Biotherapeutics2026-10-29 12:30 EST
SAB BIO to Host Third Quarter 2026 Financial Results Conference Call and Webcast on November 5, 2026, 08:30 AM ET
BRLIBio-Reference Laboratories2026-10-28 12:52 EST
OPKO Health to Report Third Quarter 2026 Financial Results on November 4, 2026
BDSXBiodesix2026-10-22 10:00 EST
Biodesix to Report Third Quarter 2026 Financial Results on November 5, 2026
SERASera Prognostics2026-10-21 20:05 EST
SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON NOVEMBER 4, 2026
BNTXBioNTech2026-10-20 10:45 EST
BioNTech to Report Third Quarter 2026 Financial Results and Corporate Update on November 3, 2026
IMVTImmunovant2026-10-21 11:00 EST
Immunovant to Report Financial Results for the Second Fiscal Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026
SNGXSOLIGENIX2026-11-06 12:30 EST
Soligenix Announces Recent Updates and Third Quarter 2026 Financial Results
AVTXAvalo Therapeutics2026-11-05 12:00 EST
Avalo Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Updates
BRLIBio-Reference Laboratories2026-11-04 21:23 EST
OPKO Health Reports Third Quarter 2026 Business Highlights and Financial Results
Exagen
Autoimmune Diagnostics Exagen provides diagnostic testing for autoimmune and rheumatic diseases. Its tests are designed to help clinicians resolve diagnostically complex cases and support ongoing disease management. AVISE CTD AVISE CTD is the company's flagship testing service for lupus and other connective-tissue diseases. It combines...
Recent company news
XGNExagen2026-10-29 13:00 EST
Exagen Inc. to Participate in Upcoming Investor Conferences
XGNExagen2026-10-27 13:00 EST
Exagen to Announce Third Quarter Financial Results on November 10, 2026
XGNExagen2026-08-04 12:00 EST
Exagen Inc. Reports Second Quarter 2026 Financial Results
XGNExagen2026-07-28 13:00 EST
Exagen Inc. to Participate in Upcoming Investor Conference
XGNExagen2026-07-21 13:00 EST
Exagen to Announce Second Quarter Financial Results on August 4, 2026
Stock data
- Close
- 7.60 USD
- Market cap
- 116.45M USD
- Exchange
- NASDAQ
- Sector
- MedTech
- Location
- United States